Hip Innovation Technology gets green light to study reverse hip system

Hip Innovation Technology received FDA approval to start a clinical study examining its reverse hip replacement system.

Advertisement

The study will look at the safety and efficacy of Hip Innovation Technology’s system in total hip patients, according to a Jan. 18 news release. Results will be evaluated with clinical, radiologic and patient-reported outcomes.

The reverse hip replacement system is a metal-on-polyethylene reverse geometry hip prosthesis. It’s designed to improve stability at extended ranges of motion and reduce the risk of dislocation.

Advertisement

Next Up in Spinal Tech

  • Zavation Medical has acquired ChoiceSpine, and Derek Kuyper will be CEO of the combined company, according to a Feb. 26…

  • Carlsmed saw significant gains in fourth-quarter and 2025 revenue, according to financial results posted Feb. 25. Five things to know:…

Advertisement

Comments are closed.